Human and experimental studies on renal eicosanoid response to long-term cadmium exposure.
In order to assess the effects of long-term exposure to cadmium (Cd) on the renal metabolism of eicosanoids, the urinary excretion of 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), and thromboxane B2 (TXB2) was determined in 37 workers exposed to Cd and in female Sprague-Dawley rats given 100 ppm Cd in drinking water for 10 months. Urinary output of sodium and calcium was also determined. The Cd-exposed workers showed an increased urinary concentration of 6-keto-PGF1 alpha, PGE2, sodium, and calcium. The rise of 6-keto-PGF1 alpha was related to Cd levels in blood and weakly correlated with urinary sodium. Calcium in urine was not related to the concentration of the metal in blood and urine. A slight elevation in urinary TXB2 was also observed in workers with blood Cd higher than 5 micrograms/liter. After 10 months of exposure to Cd, female Sprague-Dawley rats presented an enhanced urinary excretion of albumin, transferrin, beta 2-microglobulin, sodium, and PGE2 in urine. The latter was significantly correlated with albuminuria and transferrinuria. In conclusion the results show that chronic exposure to Cd induces changes in the urinary excretion of some eicosanoids. The possible relation of these changes to Cd-induced kidney dysfunction are discussed.
Cárdenas
A
A
Industrial Toxicology and Occupational Medicine Unit, School of Medicine, Catholic University of Louvain, Brussels, Belgium.
Ramis
I
I
Hotter
G
G
Roselló
J
J
Gelpí
E
E
Roels
H
H
Bernard
A
A
Lauwerys
R
R
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000118:Acetylglucosaminidase / Q000652:urine; D000419:Albuminuria / Q000139:chemically induced / Q000652:urine; D000818:Animals; D002104:Cadmium / Q000009:adverse effects* / Q000378:metabolism / Q000633:toxicity; D002118:Calcium / Q000652:urine; D015232:Dinoprostone / Q000652:urine; D015777:Eicosanoids / Q000096:biosynthesis* / Q000652:urine; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D016273:Occupational Exposure; D011507:Proteinuria / Q000139:chemically induced / Q000652:urine; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000652:urine; D013997:Time Factors; D014168:Transferrin / Q000652:urine; D001613:beta 2-Microglobulin / Q000652:urine
D015777:Eicosanoids; D014168:Transferrin; D001613:beta 2-Microglobulin; D002104:Cadmium; D015121:6-Ketoprostaglandin F1 alpha; D012964:Sodium; D000118:Acetylglucosaminidase; D015232:Dinoprostone; D002118:Calcium